Evidence map›Paper›PMID 35593889›Full record

ArticleActa neuropathologica2022

Correction to: Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.

Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, Yoshio Hashizume, Kazuko Hasegawa, Yuko Saito, Andrew C Robinson, David M A Mann, Mari Yoshida, Shigeo Murayama and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Acta neuropathologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Airi TarutaniDepartment of Brain and Neuroscience, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.
Tadashi AdachiDivision of Neuropathology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Tottori, 683-8503, Japan.
Hiroyasu AkatsuDepartment of Neuropathology, Choju Medical Institute, Fukushimura Hospital, Aichi, 441-8124, Japan.
Yoshio HashizumeDepartment of Neuropathology, Choju Medical Institute, Fukushimura Hospital, Aichi, 441-8124, Japan.
Kazuko HasegawaDivision of Neurology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, 252-0392, Japan.
Yuko SaitoDepartment of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan.
Andrew C RobinsonFaculty of Biology, Medicine and Health, School of Biological Sciences, Division of Neuroscience and Experimental Psychology, Salford Royal Hospital, The University of Manchester, Salford, M6 8HD, UK.
David M A MannFaculty of Biology, Medicine and Health, School of Biological Sciences, Division of Neuroscience and Experimental Psychology, Salford Royal Hospital, The University of Manchester, Salford, M6 8HD, UK.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Aichi, 480-1195, Japan.
Shigeo MurayamaDepartment of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan.
Masato HasegawaDepartment of Brain and Neuroscience, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. hasegawa-ms@igakuken.or.jp.ORCID http://orcid.org/0000-0001-7415-8159

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35593889
PMCPMC9217853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.